Lavipharm : Managers’ transactions announcement according to article 19
Posted at h
in --, Announcements, Consolidated Financial Results, Consolidated Financial Results 2023
Paiania, 12 May 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and following relevant notification, announces that Mr. Thomas Tseronis, Head of Sales Rx, sold 35.434 Lavipharm common shares, amounting in total to €15.732,7.